Ho-166-Chitosan
166Ho-Chitosan is a radiopharmaceutical drug available in South Korea as [...]
Lu-177-Rosopatamab
177Lu-Rosopatamab (177Lu-J591, 177Lu-TLX591, 177Lu-J591, 177Lu-ATL-101) is the Lutetium-177 labeled [...]
Lu-177-Vipivotide tetraxetan (Pluvicto™)
177Lu-Vipivotide tetratexan (177Lu-PSMA-617) is a 177Lu labeled peptide developed [...]
Lu-177-DOTAZOL
177Lu-DOTAZOL is a drug suitable for betatherapy of bone metastases [...]
Ac-225-PSMA-617
225Ac-PSMA-617 is the next generation of prostate cancer treatment following [...]
Lu-177-iPSMA
177Lu-iPSMA is the therapeutic analogue of 99mTc-iPSMA developed at [...]
Th-227-Pelgifatamab
227Th-Pelgifatamab(227Th-PSMA-TTC, 227Th-BAY2315497) is a Thorium-227 labelled PSMA-targeted full IgG antibody [...]
I-131-RPS-001
131I-RPS-001 (131I-MIP-1095) is a small radiolabeled molecule, a glutamate-urea-lysine analogue, [...]
Lu-177-CTT-1403
177Lu-CTT1403 is the therapeutic analogue of 18F-CTT1057, a phosphoramide based [...]
Lu-177-EB-PSMA-617
177Lu-EB-PSMA-617 is a PSMA-617 analogue developed in China as an [...]